Figure 3.
Kalplan-Meier analysis reveals the prognostic value of stromal MCT4: Comparison with stromal Cav-1. Stromal Cav-1 and stromal MCT4 levels were used to generate Kaplan-Meier survival curves, plotting percent overall survival (%) vs. time since diagnosis (in months). The results of this analysis were highly statistically significant (with p-values in the range of 10−12 to 10−16). This analysis identified the two high-risk groups as patients with absent stromal Cav-1 (score = 0; n = 51 patients) and high stromal MCT4 (score = 2; n = 55 patients).